Table 4.
Microorganism-derived adjuvants.
Adjuvant name | Number of Vaccines | Mechanism | Route | Licensed |
---|---|---|---|---|
Cholera toxin | 17 | Immunostimulant | Mucosal | No |
CpG DNA vaccine adjuvant | 12 | Immunostimulant | Either * | No |
MPL adjuvant | 10 | Immunostimulant | Either | As part of AS04 |
Cholera toxin B subunit | 6 | Immunostimulant | Mucosal | No |
LTR192G vaccine adjuvant | 6 | Immunostimulant | Mucosal | No |
Bordetella pertussis component vaccine adjuvant | 3 | Immunostimulant | Parenteral | Yes |
E. coli heat-labile toxin, LT | 3 | Immunostimulant | Mucosal | No |
CTA1-DD gene fusion protein | 2 | Immunostimulant | Either | No |
Etx B subunit adjuvant | 2 | Immunostimulant | Either | No |
Killed Corynebacterium parvum vaccine adjuvant | 2 | Immunostimulant | Parenteral | No |
Lipopolysaccharide vaccine adjuvant | 2 | Immunostimulant | Either | No |
LTK63 vaccine mutant adjuvant | 2 | Immunostimulant | Mucosal | No |
Corynebacterium-derived P40 vaccine adjuvant | 1 | Immunostimulant | Parenteral | No |
Flagellin vaccine adjuvant | 1 | Immunostimulant | Either | No |
LTK72 vaccine adjuvant | 1 | Immunostimulant | Mucosal | No |
MPL-SE vaccine adjuvant | 1 | Immunostimulant | Parenteral | No |
Non-toxic mutant E112K of Cholera Toxin mCT-E112K | 1 | Immunostimulant | Mucosal | No |
Ty particles vaccine adjuvant | 1 | Vehicle | Parenteral | No |
Note: *either means either mucosal or parenteral route.